Whether you're a venture capitalist or just a bill-paying Joe, you're probably wishing you were in Eric Martin's shoes right now.
Wal-Mart's acquisition of Jet.com was in some ways a return to basics for the world's largest retailer.
Jefferies initiates coverage on Ford with an underperform rating.
The Russell 2000 hit a one-year high, and Tim Seymour sees this as an encouraging sign for the overall market.
The group he has assembled, mostly businessmen, is atypical in their relative lack of economic credentials.
Here are five things you may have missed at the Rio Olympics on Monday.
Live Nation and HBO are joining forces to deliver a "live concert experience" in North America, using the music from Game of Thrones.
Donald Trump's recent comments about NATO prove that he is even more dangerous than Vladimir Putin, says Jorge Benitez, director of the news and information service NATOSource.
Some of the names on the move ahead of the open.
When Sanya Richards-Ross failed to win gold at the 2008 Olympics in Beijing as the favorite in the women's 400 meters, the only thing left to do was work harder and try again in London.
Top Wall Street strategist Tony Dwyer warned investors to not throw in the towel on this bull market just yet.
Donald Trump’s economic plan favors the rich over blue collar Americans, says Breakingviews.
Another big security flaw in Android highlights just how messed up the Google ecosystem still is when it comes to security.
While estate planning is often associated with the wealthy, financial advisors say most Americans can benefit from it.
Even as Hillary Clinton and Donald Trump slug it out, at every turn, the Ohio governor is making sure to show America he's looking toward the future.
The parents of two Americans killed in the 2012 attacks on U.S. facilities in Benghazi, Libya, filed a wrongful death lawsuit against Hillary Clinton.
Donald Trump is promising to make sweeping tax cuts but hasn't said how he'll pay for them.
Hillary Clinton will participate in the three debates set by a debate commission, her campaign said.
Valeant Pharmaceuticals reported quarterly earnings and revenue that fell short of analysts' expectations on Tuesday.